Sysmex Corporation (SSMXY) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Instruments & Supplies 산업에서 운영. 본사 소재지는 Kobe, 일본. 현재 CEO는 Hisashi Ietsugu.
SSMXY 을(를) 보유 IPO 날짜 2011-10-17, 10,042 명의 정규직 직원, 에 상장 Other OTC, 시가총액 $5.5B.
Sysmex Corporation is a Japanese diagnostic instrument manufacturer headquartered in Kobe that develops, manufactures, and sells hematology analyzers, immunochemistry systems, flow cytometers, and related reagents and software globally. The company's product portfolio includes white blood cell differentiation instruments, urine analysis systems, infectious disease and tumor marker assays, cancer diagnostic systems, and digital medicine platforms, serving hospitals, research institutions, and medical centers across approximately 190 countries. Beyond diagnostic instruments, Sysmex provides laboratory information system software, facility management services, nucleic acid analogs, IT solutions, and medical robotics, with a strategic alliance with QIAGEN for cancer companion diagnostics development. Founded in 1968, the company has established itself as a comprehensive in vitro diagnostics provider serving both public and private healthcare institutions worldwide.
